BioMistral: Open-Source Pretrained LLMs for the Medical Domain (arXiv 2402.10373)

Forum topic · 小凯 · 2026-07-05

Summary

BioMistral is a family of open-source large language models for the medical domain, presented in a February 2024 arXiv paper (2402.10373) by Labrak et al. from the University of Nantes and related institutions. The work builds BioMistral 7B by continued pretraining of the Mistral 7B base model on the PubMed Central Open Access corpus, adapting a general-purpose LLM to biomedical text. The models are evaluated on a multilingual benchmark suite covering ten languages, using translated versions of medical multiple-choice question-answering datasets to probe both domain knowledge and cross-lingual transfer. The paper also examines lightweight quantization for on-device clinical deployment and includes safety assessments of the models' behavior on medical content. BioMistral is released fully openly — model weights, training data pipeline, and evaluation code — to support reproducible research and position open models as a privacy-conscious alternative to proprietary LLMs in healthcare, where sensitive clinical data restricts the use of cloud APIs. The accompanying English forum post situates the work within the broader vertical-domain LLM landscape and discusses its relevance to retrieval, evaluation, and deployment practices.

BioMistral: A Collection of Open-Source Pretrained Large Language Models for Medical Domains

> Source: arXiv:2402.10373, February 2024. Authors: Yanis Labrak, Adrien Bazoge, Emmanuel Morin, Pierre-Antoine Gourraud, Mickael Rouvier, Richard Dufour.

One-line Summary

BioMistral is a fully open-source collection of LLMs adapted to the medical domain by continued pretraining of Mistral 7B on PubMed Central, evaluated multilingually on medical QA benchmarks with attention to quantization and safety.

Background and Motivation

General-purpose LLMs show strong medical knowledge, but proprietary APIs are often unusable in healthcare settings because clinical data is sensitive and cannot be shared with external services. The BioMistral project addresses this gap by releasing an open, domain-adapted model family that organizations can host on-premises, with full transparency of weights, training data, and evaluation.

Approach

Base model: Mistral 7B, chosen for its strong open-weight performance.
Domain adaptation: continued pretraining on the PubMed Central Open Access subset of the biomedical literature.
Openness: model weights, data preparation pipeline, and evaluation code are all released to support reproducibility.

Evaluation

Multilingual benchmark: the models are evaluated on medical multiple-choice QA datasets across ten languages, using translated benchmarks to test cross-lingual transfer from the English-centric biomedical corpus.
Quantization: the paper studies lightweight quantization of BioMistral to assess feasibility of on-device / low-resource deployment in clinical environments.
Safety: the models are probed for safe behavior on medical content, an essential consideration for clinical-facing systems.

Key Takeaways

1. Continued pretraining on domain corpora is an effective, fully open recipe for medical LLMs. 2. Domain-adapted open models can rival much larger proprietary systems on some medical benchmarks, while keeping patient data local. 3. Quantization makes open medical LLMs practical for on-device use, and safety evaluation remains a necessary guardrail before clinical use.

Caveats

The forum post is a template-style entry; quantitative benchmark numbers should be verified against the original PDF before citation. Evaluations rely on translated QA sets, so results may not fully reflect real clinical language use.

Reference

Labrak et al., *BioMistral: A Collection of Open-Source Pretrained Large Language Models for Medical Domains*, arXiv:2402.10373, 2024. https://arxiv.org/abs/2402.10373